Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, WiCell Offering CGH+SNP Microarray Service

NEW YORK (GenomeWeb News) – Agilent Technologies and WiCell said today they are teaming up to offer comparative genomic hybridization plus single nucleotide polymorphism microarray analysis services using the Agilent SurePrint G3 Human Genome CGH+SNP Microarray.

The microarray detects copy number changes by both SNP and CGH while simultaneously delivering copy-neutral change information such as loss or absence of heterozygosity, the companies said. They added that the assay maintains the high-resolution quality achieved with CGH-only microarrays.

"WiCell's considerable experience and know-how in cytogenetic analysis and their large CGH dataset for embryonic and induced pluripotent stem cells partners well with Agilent's technology to enable robust detection capabilities vital for research and commercial development," Kathleen Shelton, senior director of genomics marketing at Agilent, said in a statement.

Financial and other terms of the partnership were not disclosed.

WiCell is based in Madison, Wis., and offers cytogenetic testing of mouse and human embryonic stem cells and induced pluripotent stem cells.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.